Titre:
  • An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: the trastuzumab case.
Auteur:Ades, F; Senterre, Christelle; Zardavas, Dimitros; De Azambuja, Evandro; Popescu, Razvan; Parent, Florence; Piccart-Gebhart, Martine
Informations sur la publication:European journal of cancer, 50, 18, page (3089-3097)
Statut de publication:Publié, 2014-12
Sujet CREF:Cancérologie
Santé publique
Mots-clés:Breast cancer
Drug reimbursement
European Union
Health expenditure
Health policy
Trastuzumab
MeSH keywords:Antibodies, Monoclonal, Humanized -- economics -- therapeutic use
Antineoplastic Agents -- economics -- therapeutic use
Breast Neoplasms -- drug therapy -- economics
Chemotherapy, Adjuvant -- economics
Cost-Benefit Analysis
Drug Approval -- economics
European Union -- economics
Female
Health Expenditures -- statistics & numerical data
Health Policy -- economics
Humans
Neoplasm Metastasis
Reimbursement Mechanisms
Time Factors
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2014.09.011
info:pii/S0959-8049(14)00961-7
info:scp/84925225626
info:pmid/25446375